1. ScholarBank@NUS

Eng King Tan

rp09622

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
Main Affiliation
 
Faculty
 
Email
gmstek@nus.edu.sg
 

Publications

Results 41-60 of 125 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
41Mar-2011New LRRK2 variants identified in Parkinson's diseaseTan, E.K. ; Schapira, A.H.
422007Neurovascular compression syndromes and hypertension: Clinical relevanceTan E.-K. ; Chan L.-L. 
431-Mar-2022Neurodegenerative diseases associated with non-coding CGG tandem repeat expansionsZhou, Zhidong ; Jankovic, J; Ashizawa, T; Tan, Eng King 
42016Neurodegeneration: Etiologies and New Therapies 2016Tan E.K. ; Srivastava A.K.; Arnold W.D.; Singh M.P.; Zhang Y.
52000Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystoniaTan E.-K. ; Jankovic J.; Cardoso F.; Oliveira L.D.
62006Movement disorders associated with hyperthyroidism: Expanding the phenotype [1]Tan E.-K. ; Chan L.-L. 
72001Motor restlessnessTan E.K. ; Ondo W.G.
82017Mood and neural correlates of excessive daytime sleepiness in Parkinson's diseaseWen M.-C. ; Chan L.L. ; Tan L.C.S. ; Tan E.K. 
9Jul-2008Molecular biology changes associated with LRRK2 mutations in Parkinson's diseaseYi, W.L.; Tan, E.-K. 
102018Modelling Alzheimer's disease: Insights from in vivo to in vitro three-dimensional culture platformsRanjan V.D.; Qiu L. ; Tan E.K. ; Zeng L. ; Zhang Y.
112015Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson diseaseChao Y.X.; Ng E.Y.; Foo J.N.; Liu J.; Zhao Y.; Tan E.-K. 
122017Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative DiseasesZhou Z.-D. ; Saw W.-T.; Tan E.-K. 
132017Mild cognitive impairment in Parkinson's disease: A distinct clinical entity?Wen M.-C. ; Chan L.L. ; Tan L.C.S. ; Tan E.K. 
142015microRNAs and Neurodegenerative DiseasesQiu L.; Tan E.K. ; Zeng L. 
152013Message from the editorTan E.K. 
162004MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic ChineseLee C.G. ; Tang K.; Cheung Y.B. ; Wong L.P.; Tan C.; Shen H.; Zhao Y.; Pavanni R. ; Lee E.J. ; Wong M.C. ; Chong S.S. ; Tan E.K. 
17Oct-2008Lrrk2 R1628P in non-Chinese Asian racesTan, E.-K. ; Tang, M.; Tan, L.C.; Wu, Y.-R.; Wu, R.-M.; Ross, O.A.; Zhao, Y.
182006LRRK2 G2019S and I2020T mutations are not common in Alzheimer's disease and vascular dementiaLee E.; Hui S.; Ho G.; Tan E.K. ; Chen C.P.
19Apr-2011LRRK2 as a therapeutic target in Parkinson's diseaseTan, E.K. ; Schapira, A.H.
202009Long-term treatment outcome with different formulations of botulinum toxinPerez-Saldana M.T.; Tan E.K. ; Burguera J.A.